Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MC2 Therapeutics A/S
A/S
Active
CVR 29526346
Agern Alle 24-26, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2006 · 20 years old
10 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
MC2 Therapeutics A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
8M
16M
24M
32M
16M
2020
28M
2021
25M
2022
26M
2023
24M
2024
EBITDA
DKK millions
3M
2M
1M
1M
0M
1M
2020
2M
+100%
2021
2M
0%
2022
2M
0%
2023
1M
-50%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
15.938
27.734
25.008
26.355
24.493
Staff expenses
-14.706
-26.007
-23.156
-24.445
-23.237
EBITDA
1.232
1.727
1.852
1.910
1.257
Depreciation & amort.
-245
-276
-225
-241
-100
EBIT
987
1.452
1.628
1.670
1.157
Net financials
-88.057
-26.675
-102.959
-43.521
-54.164
Profit before tax
-87.070
-25.223
-101.331
-41.851
-53.007
Tax
-129
-0
-0
-0
-0
Net profit
-86.941
-25.223
-101.331
-41.851
-53.007
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
36.145
51.603
38.592
30.589
64.386
Equity
13.930
-21.098
-122.650
-164.534
-218.391
Long-term debt
1.058
914
157.155
190.449
270.165
Short-term debt
11.675
71.786
4.087
4.674
12.612
Total debt
12.733
72.700
161.242
195.123
282.777
Financial ratios
5-year trend
EBITDA margin (of gross profit)
5.1%
This company
2020
2024
Equity ratio
-339.2%
This company
38.2%
Market median
-988% vs market
2020
2024
Return on equity
-5300693100.0%
This company
18.4%
Market median
-28808114774% vs market
2020
2024
Net profit margin (of gross profit)
-216.4%
This company
2020
2024
Asset turnover (of gross profit)
0.38×
This company
2020
2024
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on MC2 Therapeutics A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
